Eyeing Allegra OTC, Sanofi buys Chattem for $1.9B
Sanofi-Aventis continues its shopping spree with a $1.9 billion deal for the consumer healthcare group Chattem. Aided by the support of Chattem’s board, the French drugmaker will mount a tender offer for all of its stock at $93.50 per share. That’s a 34 percent premium over Friday’s closing price. The deal will
